Tim Kempster

179 days ago

Naughty Bear Tim Kempster schooled in GCSE science yet again by Stuart Ashman

Oh dear, oh dear, naughty Tim keeps pushing the sort od science that would shame my four year old daughter or perhaps even my cats in support of his undeclared short position in Skinbiotherapeutics (SBTX). He thinks Croda (CRDA)has spaffed £10 million for no reason as, I am sure he knows its business better than Croda does. Luckily Stuart Ashman is here to explain in terms simple enough for even Tim to grasp…

180 days ago

Tom Winnifrith Bearcast No 2: picking a fight with Tim Kempster

I'm not really picking a fight with the short seller as he is basically a good chap but he has tweeted on Optibiotix (OPT) and Skinbiotherapeutics (SBTX) and he has, I think, got his facts wrong. For someone who may have an undeclared short position, that is perhaps unwise. I have swapped emails with at one CEO. If the other gets back to me I shall let you know but he is a bearded poltroon so many not.. I am also rowing with our in-house BB savant PL on NPVs ref Ariana (AAU). I cover Celadon (CEL) and revise my sordid price targets for Wishbone (WSBN) after news of a placing. I fear that the brothers in bromance, Richard Poulden and David Lenigas, are losing their ramping touch.

257 days ago

KERBOOM: Argo Blockchain and the stinking GEM deal, Evil Banksta has more, surely the FCA must intervene?

Earlier today Evil Banksta pointed out that the maths on today’s refinancing and acquisition by technically insolvent Argo Blockchain (ARB) just made no sense at all. The deal stinks., Now he pipes up with added detail which is just damning. The FCA should be all over this. Evil Banksta notes:

373 days ago

Hemogenyx is a short – target 0p

Yes: you can get borrow. Tim Kempster is short and you should join him at 1.2p, my target for Hemogenyx (HEMO) is 0p. Here is why.

373 days ago

Tim Kempster warns those foolish enough to own Hemogenyx

I have warned folks repeatedly about this dog. I think that short seller Tim Kempster is actually being rather too generous with his assessment of Hemogenyx (HEMO). As folks start to panic…

668 days ago

Harland & Wolff – deeply discounted, keep the lights on, placing imminent? Tim Kempster

Shorter Tim Kempster says that by his sums Harland & Wolff (HARL) runs out of money either in December or early January. My analysis on this website has been permanently bearish and I agree with Tim. And in that vein I see that the shares are weaker today, at 13.5p having been pumped in recent weeks by ramptastic announcements. I also see that…

2072 days ago

Tim Kempster beats me to it: Letter to AIM Regulation & FCA re Versariens' shambles of an RNS today & Neill Ricketts share deals

As I noted earlier, the RNS issued by Versarien (VRS) is a shambles and opens up all sorts of questions about share dumping by boss Lyin’ Neill Ricketts last April. I was set to contact AIM Regulation and the FCA about it but it seems that valiant Tim Kempster has beaten me to it. The Regulators really do need to act on this at once. Tim writes